🔗 Permalink

Inventor profile of:

Fabio RANCATI

City:

Parma

Country:

Italy

Published Applications:

35

Last publication date:

2026-03-26

Top Assignees for applications by Fabio RANCATI

The entities that hold a legal rights for patent applications filed by inventor RANCATI Fabio:

Chiesi Farmaceutici S.p.A. 34 Parma, Italy
CHIESI FARMACEUTICI S.P. A. 1 Parma, Italy
CHIESI FARMACEUTISI S.p.A. 1 Parma, Italy

Recent patent applications by RANCATI Fabio

Fabio RANCATI from Parma, IT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-26

US20260085077A1

Chemistry; metallurgy

HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS

#2 | 2024-12-26

US20240425482A1

Chemistry; metallurgy

PYRROLIDINE DERIVATIVES AS DDRS INHIBITORS

#3 | 2024-11-28

US20240391936A1

Chemistry; metallurgy

TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS

#4 | 2024-08-22

US20240279240A1

Chemistry; metallurgy

HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS

#5 | 2024-07-04

US20240217967A1

Chemistry; metallurgy

INDOLINE DERIVATIVES AS DDRS INHIBITORS

#6 | 2024-06-27

US20240209001A1

Chemistry; metallurgy

HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS

#7 | 2024-06-20

US20240199635A1

Chemistry; metallurgy

TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS

#8 | 2024-06-13

US20240190847A1

Chemistry; metallurgy

INDOLINE DERIVATIVES AS DDR1 AND DDR2 INHIBITORS

#9 | 2024-05-23

US20240166651A1

Chemistry; metallurgy

HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS

#10 | 2024-03-21

US20240092792A1

Chemistry; metallurgy

DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS

#11 | 2024-03-21

US20240092791A1

Chemistry; metallurgy

DIHYDROFUROPYRIDINE DERIVATIVES AS RHO-KINASE INHIBITORS

#12 | 2024-03-21

US20240092790A1

Chemistry; metallurgy

DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS

#13 | 2024-03-14

US20240082223A1

Human necessities

DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS

#14 | 2023-07-20

US20230227447A1

Chemistry; metallurgy

BENZYLAMINE DERIVATIVES AS DDRS INHIBITORS

#15 | 2021-09-16

US20210284639A1

Chemistry; metallurgy

TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS

#16 | 2021-08-19

US20210253568A1

Chemistry; metallurgy

AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS

#17 | 2021-01-28

US20210023080A1

Human necessities

Tyrosine analogues derivatives as Rho-kinase inhibitors

#18 | 2020-12-17

US20200392133A1

Chemistry; metallurgy

Azaindole derivatives as Rho-kinase inhibitors

#19 | 2020-12-03

US20200377500A1

Chemistry; metallurgy

Meta tyrosine derivatives as rho-kinase inhibitors

#20 | 2020-10-22

US20200331912A1

Chemistry; metallurgy

Oxadiazole derivatives as Rho-Kinase Inhibitors

#21 | 2020-03-12

US20200079774A1

Chemistry; metallurgy

Tyrosine amide derivatives as Rho-Kinase inhibitors

#22 | 2018-08-02

US20180215758A1

Chemistry; metallurgy

Tyrosine amide derivatives as Rho-kinase inhibitors

#23 | 2018-06-21

US20180170939A1

Chemistry; metallurgy

Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitors

#24 | 2018-01-18

US20180016267A1

Chemistry; metallurgy

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

#25 | 2017-06-08

US20170158694A1

Chemistry; metallurgy

Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

#26 | 2017-05-04

US20170119753A1

Human necessities

Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

#27 | 2016-12-01

US20160346271A1

Human necessities

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

#28 | 2016-08-18

US20160235734A1

Human necessities

Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

#29 | 2015-05-21

US20150139916A1

Chemistry; metallurgy

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

#30 | 2015-05-14

US20150133491A1

Chemistry; metallurgy

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

#31 | 2014-06-12

US20140163066A1

Human necessities

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

#32 | 2014-06-12

US20140161736A1

Human necessities

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

#33 | 2013-02-21

US20130045169A1

Chemistry; metallurgy

Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity

#34 | 2013-02-07

US20130034504A1

Chemistry; metallurgy

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

#35 | 2011-08-18

US20110201580A1

Chemistry; metallurgy

Pyrrolidine compounds,pharmaceutical compositions containing the same, devices containing the same, and methods of treating asthma or chronic obstructive pulmonary disease by administering the same

InventorID:

77900 ⎘